Abivax (ABVX) EV to EBIT (2023 - 2026)
Abivax (ABVX) EV to EBIT (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EV to EBIT |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,783.19 Bn | 1,783.13 Bn | - | -254,021.30 |
| 2 | Akari Therapeutics | 984.50 Bn | 984.50 Bn | - | -33,363.69 |
| 3 | BeOne Medicines | 471.21 Bn | 466.41 Bn | 1.35 Bn | 679.97 |
| 4 | Vertex Pharmaceuticals | 124.47 Bn | 117.23 Bn | 2.59 Bn | 25.04 |
| 5 | Regeneron Pharmaceuticals | 72.38 Bn | 63.63 Bn | 3.31 Bn | 17.53 |
| 6 | Belite Bio | 60.76 Bn | 60.76 Bn | - | -1.49 |
| 7 | Argenx Se | 54.76 Bn | 49.58 Bn | 1.41 Bn | 30.97 |
| 8 | Alnylam Pharmaceuticals | 38.04 Bn | 35.03 Bn | 959.66 Mn | 46.58 |
| 9 | Revolution Medicines | 35.98 Bn | 35.98 Bn | - | -25.95 |
| 10 | Abivax | 9.65 Bn | 9.65 Bn | - | -33.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 23, 2026 | -34.96 |
| Jul 22, 2026 | -34.57 |
| Jul 21, 2026 | -35.74 |
| Jul 20, 2026 | -35.05 |
| Jul 17, 2026 | -36.42 |
| Jul 16, 2026 | -36.72 |
| Jul 15, 2026 | -36.50 |
| Jul 14, 2026 | -35.95 |
| Jul 13, 2026 | -36.24 |
| Jul 10, 2026 | -37.28 |
| Jul 9, 2026 | -37.51 |
| Jul 8, 2026 | -36.92 |
| Jul 7, 2026 | -37.89 |
| Jul 6, 2026 | -38.37 |
| Jul 2, 2026 | -38.55 |
| Jul 1, 2026 | -35.33 |
| Jun 30, 2026 | -35.51 |
| Jun 29, 2026 | -25.62 |
| Jun 26, 2026 | -25.98 |
| Jun 25, 2026 | -24.62 |